Audits and Reviews
Lachman Consultants can assess organizations' compliance with:
- GMP (good manufacturing practice) for intermediates, active pharmaceutical ingredients (APIs), and finished drug products
- QSR (medical device "GMP")
- GCP (good clinical practice)
- GLP (good laboratory practice)
- GPP (good promotion practice)
- DEA (Drug Enforcement Agency)
We also have extensive experience in:
- Performing "mock" FDA pre-approval inspections-helping to ensure that problem areas are identified and addressed before the real inspection
- Developing drug diversion prevention and counterfeit investigation programs
- Helping organizations ensure compliance with the Prescription Drug Marketing Act (PDMA)
- Auditing adverse drug event (ADE) programs-from collection and evaluation through reporting and follow-up
- Qualifying vendors
- Performing due diligence
- Conducting regulatory audits
- Auditing documentation, including application integrity audits
- Verifying activities of the regulatory committee
Back to FDA-Related Services